Treatment of acquired factor VIII inihibitor with recombinant activated factor VIIa: Data from the Italian registry of acquired hemophilia

Francesco Baudo; Francesco De Cataldo; Gianluca Gaidano

Treatment of acquired factor VIII inihibitor with recombinant activated factor VIIa: Data from the Italian registry of acquired hemophilia

Francesco Baudo
, Francesco De Cataldo
, Gianluca Gaidano

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90% of the episodes, indicating the efficacy of rFVIIa in HA.

Lingua originale	Inglese
pagine (da-a)	759-760
Numero di pagine	2
Rivista	Haematologica
Volume	89
Numero di pubblicazione	6
Stato di pubblicazione	Pubblicato - giu 2004

Altri file e collegamenti

Link to publication in Scopus

Cita questo

@article{111f6ee9edcb4716adbcfcd824ec290c,

title = "Treatment of acquired factor VIII inihibitor with recombinant activated factor VIIa: Data from the Italian registry of acquired hemophilia",

abstract = "We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90\% of the episodes, indicating the efficacy of rFVIIa in HA.",

keywords = "Acquired hemophilia, Bleeding, RFVIIa therapy",

author = "Francesco Baudo and \{De Cataldo\}, Francesco and Gianluca Gaidano",

year = "2004",

month = jun,

language = "English",

volume = "89",

pages = "759--760",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "6",

}

TY - JOUR

T1 - Treatment of acquired factor VIII inihibitor with recombinant activated factor VIIa

T2 - Data from the Italian registry of acquired hemophilia

AU - Baudo, Francesco

AU - De Cataldo, Francesco

AU - Gaidano, Gianluca

PY - 2004/6

Y1 - 2004/6

N2 - We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90% of the episodes, indicating the efficacy of rFVIIa in HA.

AB - We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90% of the episodes, indicating the efficacy of rFVIIa in HA.

KW - Acquired hemophilia

KW - Bleeding

KW - RFVIIa therapy

UR - https://www.scopus.com/pages/publications/3042571427

M3 - Article

SN - 0390-6078

VL - 89

SP - 759

EP - 760

JO - Haematologica

JF - Haematologica

IS - 6

ER -

Treatment of acquired factor VIII inihibitor with recombinant activated factor VIIa: Data from the Italian registry of acquired hemophilia

Abstract

Altri file e collegamenti

Fingerprint

Cita questo